Alexa B.

Director Of Drug Development, Program Management at Recursion Pharmaceuticals

Alexa B. has a robust background in drug development and program management, currently serving as the Director of Drug Development, Program Management at Recursion. Previous roles include Independent Consultant at Brown Scientific Consulting, Director of Program Management and Medical Writing at Nuvation Bio, Director of Medical Writing at Portola Pharmaceuticals, and Senior Manager of Medical Writing at Ultragenyx Pharmaceutical Inc. This extensive experience in medical writing and program management showcases expertise in the pharmaceutical industry.

Links

Previous companies


Org chart

No direct reports

Teams

This person is not in any teams


Offices

This person is not in any offices


Recursion Pharmaceuticals

13 followers

Recursion is a clinical-stage biotechnology company combining experimental biology and automation with artificial intelligence in a massively parallel system to efficiently discover potential drugs for diverse indications, including genetic disease, inflammation, immunology, and infectious disease.